ONE PACKET. ONE DOSE. ONE TIME.

Solosec® (secnidazole) is designed to deliver a full course of therapy in a single oral dose.1

  • Easy to take1,2
  • No alcohol restriction1
    • In vitro drug alcohol studies show that Solosec does not inhibit the enzyme that metabolizes alcohol1
  • Statistically significant efficacy in pivotal studies1,3,4
  • Generally well tolerated with a low incidence of side effects1
    • In clinical studies, the most common adverse events occurring in (≥2%) of patients receiving SOLOSEC 2g oral granules were vulvovaginal candidiasis (9.6%), headache (3.6%), nausea (3.6%), dysgeusia (3.4%), vomiting (2.5%), diarrhea (2.5%), abdominal pain (2.0%), and vulvovaginal pruritus (2.0%)1

HELP PATIENTS SAVE

Patients may pay as little as $25 for a Solosec prescription.

Find out how

REFERENCES:

  1. SOLOSEC [prescribing information]. Baltimore, MD: Lupin Pharmaceuticals, Inc; 2017.
  2. Data on File. Physician Research. Advantage Healthcare, Inc. Prepared December 23, 2014.
  3. Schwebke JR, Morgan FG Jr, Koltun W, Nyirjesy P. A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis. Am J Obstet Gynecol. 2017;217(6):678.e1-678.e9. doi: 10.1016/j.ajog.2017.08.017.
  4. Hillier SL, Nyirjesy P, Waldbaum AS, et al. Secnidazole treatment of bacterial vaginosis: a randomized controlled trial. Obstet Gynecol. 2017;130(2):379-386.